Earlier today, Abbott announced it had received approval from the U.S. Food and Drug Administration (FDA) for its Tecnis Symfony® Intraocular Lenses (IOLs) for the treatment of cataracts.
The product is reportedly the only lens in the U.S. that provide a full range of continuous high-quality vision following cataract surgery, while also mitigating the effects of presbyopia by helping people focus on near objects. The FDA approval includes a version of the lens for people with astigmatism, the Tecnis Symfony Toric IOL.
Click here to read the full press release from Abbott.
Click here to read the full press release from the U.S. FDA.